Mitoxantrone in combination with etoposide and prednimustine in patients older than 70 years with unfavorable non-Hodgkin's lymphoma: a prospective study in 52 patients

Semin Hematol. 1994 Apr;31(2 Suppl 3):13-22.

Authors

U Tirelli¹, V Zagonel, R Sorio, D Errante, R Talamini, A Carbone, S Monfardini

Affiliation

¹ Division of Medical Oncology and AIDS, Centro di Riferimento Oncologico, Aviano, Italy.

PMID: 8073302

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase II
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Combined Modality Therapy
Etoposide / administration & dosage
Etoposide / adverse effects
Female
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Lymphoma, Non-Hodgkin / pathology
Lymphoma, Non-Hodgkin / radiotherapy
Male
Mitoxantrone / administration & dosage
Mitoxantrone / adverse effects
Prednimustine / administration & dosage
Prednimustine / adverse effects
Prospective Studies
Remission Induction

Substances

Etoposide
Prednimustine
Mitoxantrone

Supplementary concepts

VMP regimen